Efficacy and adverse effect of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a meta-analysis

doi:10.3969/j.issn.1672-3384.2017.01.005

LIANG Liang, ZHAO Ming, ZHU Yuan-chao , HU Xin, YANG Li-ping

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (1) : 25-32.

PDF(987 KB)

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (1) : 25-32. DOI: 10.3969/j.issn.1672-3384.2017.01.005

Original Paper

Efficacy and adverse effect of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a meta-analysis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 15(1): 25-32 https://doi.org/10.3969/j.issn.1672-3384.2017.01.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(987 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2016-03-18	2017-01-15
Issue Date
2017-01-15

Please choose a citation manager

Content to export